Appendix A
References
Alagapan, S., K. S. Choi, S. Heisig, P. Riva Posse, A. Crowell, V. Tiruvadi, M. Obatusin, A. Veerakumar, A. Waters, R. Gross, S. Quinn, L. Denison, M. O’Shaughnessy, M. Connor, G. Canal, J. Cha, R. Hershenberg, T. Nauvel, I. Faiçal, and C. Rozell. 2023. Cingulate dynamics track depression recovery with deep brain stimulation. Nature 622:130–138.
Aquilina, O. 2006. A brief history of cardiac pacing. Images in Paediatric Cardiology 8(2):17–81.
Basu, I., A. Yousefi, B. Crocker, R. Zelmann, A. C. Paulk, N. Peled, K. K. Ellard, D. S. Weisholtz, G. R. Cosgrove, T. Deckersbach, U. T. Eden, E. N. Eskandar, D. D. Dougherty, S. S. Cash, and A. S. Widge. 2023. Closed-loop enhancement and neural decoding of cognitive control in humans. Nature Biomedical Engineering 7(4):576–588.
Bergfeld, I. O., M. Mantione, M. L. Hoogendoorn, H. G. Ruhé, P. Notten, J. van Laarhoven, I. Visser, M. Figee, B. P. de Kwaasteniet, F. Horst, A. H. Schene, P. van den Munckhof, G. Beute, R. Schuurman, and D. Denys. 2016. Deep brain stimulation of the ventral anterior limb of the internal capsule for treatment-resistant depression: A randomized clinical trial. JAMA Psychiatry 73(5):456–464.
Bilge, M. T., A. K. Gosai, and A. S. Widge. 2018. Deep brain stimulation in psychiatry: Mechanisms, models, and next-generation therapies. Psychiatric Clinics 41(3):373–383.
Borovečki, F., R. Perković, N. Kovacs, P. A. LeWitt, M. R. Bar, and R. Katzenschlager. 2023. Are Parkinson’s disease patients referred too late for device-aided therapies, and how can better informed and earlier referrals be encouraged? Journal of Neural Transmission 130(11):1405–1409.
Chitnis, S., B. Haque, N. Ahmed, A. Oblack, M. Salinas, B. McDaniels, N. Pouratian, and U. Yazdani. 2023. Patient perceptions and knowledge of deep brain stimulation (DBS) in Parkinson’s disease (PD) (KNOW-DBS) (P5-11.015). Neurology 100(17 Suppl 2):3540.
Davis, R. A., J. Giordano, D. B. Hufford, S. A. Sheth, P. Warnke, A. S. Widge, R. M. Richardson, J. M. Rosenow, P. J. Rossi, and E. A. Storch. 2021. Restriction of access to deep brain stimulation for refractory ocd: Failure to apply the federal parity act. Frontiers in Psychiatry 12:706181.
Deng, Z. D., B. Luber, N. L. Balderston, M. Velez Afanador, M. M. Noh, J. Thomas, W. C. Altekruse, S. L. Exley, S. Awasthi, and S. H. Lisanby. 2020. Device-based modulation of neurocircuits as a therapeutic for psychiatric disorders. Annual Review of Pharmacology and Toxicology 60:591–614.
Denys, D., I. Graat, R. Mocking, P. de Koning, N. Vulink, M. Figee, P. Ooms, M. Mantione, P. van den Munckhof, and R. Schuurman. 2020. Efficacy of deep brain stimulation of the ventral anterior limb of the internal capsule for refractory obsessive-compulsive disorder: A clinical cohort of 70 patients. American Journal of Psychiatry 177(3):265–271.
DiLuca, M., and J. Olesen. 2014. The cost of brain diseases: A burden or a challenge? Neuron 82(6):1205–1208.
Dougherty, D. D., A. R. Rezai, L. L. Carpenter, R. H. Howland, M. T. Bhati, J. P. O’Reardon, E. N. Eskandar, G. H. Baltuch, A. D. Machado, D. Kondziolka, C. Cusin, K. C. Evans, L. H. Price, K. Jacobs, M. Pandya, T. Denko, A. R. Tyrka, T. Brelje, T. Deckersbach, C. Kubu, and D. A. Malone Jr. 2015. A randomized sham-controlled trial of deep brain stimulation of the ventral capsule/ventral striatum for chronic treatment-resistant depression. Biological Psychiatry 78(4):240–248.
Goman, A. M., and F. R. Lin. 2016. Prevalence of hearing loss by severity in the United States. American Journal of Public Health 106(10):1820–1822.
Holtzheimer, P. E., and H. S. Mayberg. 2011. Deep brain stimulation for psychiatric disorders. Annual Review of Neuroscience 34:289–307.
Kedia, R., and M. Saeed. 2012. Implantable cardioverter-defibrillators: Indications and unresolved issues. Texas Heart Institute Journal 39(3):335-41.
Kempster, P. A., D. R. Williams, M. Selikhova, J. Holton, T. Revesz, and A. J. Lees. 2007. Patterns of levodopa response in Parkinson’s disease: A clinico-pathological study. Brain 130(8):2123–2128.
Krauss, J. K., N. Lipsman, T. Aziz, A. Boutet, P. Brown, J. W. Chang, B. Davidson, W. M. Grill, M. I. Hariz, and A. Horn. 2021. Technology of deep brain stimulation: Current status and future directions. Nature Reviews Neurology 17(2):75–87.
Lee, K. H., S.-Y. Chang, D. W. Roberts, and U. Kim. 2004. Neurotransmitter release from high-frequency stimulation of the subthalamic nucleus. Journal of Neurosurgery 101(3):511–517.
Lökk, J. 2011. Lack of information and access to advanced treatment for Parkinson’s disease patients. Journal of Multidisciplinary Healthcare 4:433–439.
Lozano, A. M., and N. Lipsman. 2013. Probing and regulating dysfunctional circuits using deep brain stimulation. Neuron 77(3):406–424.
Marjenin, T., P. Scott, A. Bajaj, T. Bansal, B. Berne, K. Bowsher, A. Costello, J. Doucet, E. Franca, and C. Ghosh. 2020. FDA perspectives on the regulation of neuromodulation devices. Neuromodulation: Technology at the Neural Interface 23(1):3–9.
Moore, G. 2016. Crossing the chasm: Marketing and selling disruptive products to mainstream customer. 3rd ed. New York: Harper Business.
Nagrale, S. S., A. Yousefi, T. I. Netoff, and A. S. Widge. 2023. In silico development and validation of Bayesian methods for optimizing deep brain stimulation to enhance cognitive control. Journal of Neural Engineering 20(3):036015.
Nassiri, A. M., D. L. Sorkin, and M. L. Carlson. 2022. Current estimates of cochlear implant utilization in the United States. Otology & Neurotology 43(5):e558–e562.
Okun, M. S. 2012. Deep-brain stimulation for Parkinson’s disease. New England Journal of Medicine 367(16):1529–1538.
Pearson, C., A. Hartzman, D. Munevar, M. Feeney, R. Dolhun, V. Todaro, S. Rosenfeld, A. Willis, and J. C. Beck. 2023. Care access and utilization among Medicare beneficiaries living with Parkinson’s disease. npj Parkinsons Disease 9:108.
Rossi, P. J., J. Giordano, and M. S. Okun. 2017. The problem of funding off-label deep brain stimulation: Bait-and-switch tactics and the need for policy reform. JAMA Neurology 74(1):9–10.
Sarica, C., C. R. Conner, K. Yamamoto, A. Yang, J. Germann, M. M. Lannon, N. Samuel, M. Colditz, B. Santyr, C. T. Chow, C. Iorio-Morin, D. H. Aguirre-Padilla, S. T. Lang, A. Vetkas, C. Cheyuo, A. Loh, G. Darmani, O. Flouty, V. Milano, M. Paff, M. Hodaie, S. K. Kalia, R. P. Munhoz, A. Fasano, and A. M. Lozano. 2023. Trends and disparities in deep brain stimulation utilization in the United States: A nationwide inpatient sample analysis from 1993 to 2017. Lancet Regional Health Americas 26:100599.
Schermer, M. 2011. Ethical issues in deep brain stimulation. Frontiers in Integrative Neuroscience 5:17.
Tawfik, V. L., S.-Y. Chang, F. L. Hitti, D. W. Roberts, J. C. Leiter, S. Jovanovic, and K. H. Lee. 2010. Deep brain stimulation results in local glutamate and adenosine release: Investigation into the role of astrocytes. Neurosurgery 67(2):367.
Vedam-Mai, V., K. Deisseroth, J. Giordano, G. Lazaro-Munoz, W. Chiong, N. Suthana, J.-P. Langevin, J. Gill, W. Goodman, and N. R. Provenza. 2021. Proceedings of the Eighth Annual Deep Brain Stimulation Think Tank: Advances in optogenetics, ethical issues affecting DBS research, neuromodulatory approaches for depression, adaptive neurostimulation, and emerging DBS technologies. Frontiers in Human Neuroscience 15:169.
Wichmann, T., M. R. DeLong, J. Guridi, and J. A. Obeso. 2011. Milestones in research on the pathophysiology of Parkinson’s disease. Movement Disorders 26(6):1032–1041.
Widge, A. S., S. Zorowitz, I. Basu, A. C. Paulk, S. S. Cash, E. N. Eskandar, T. Deckersbach, E. K. Miller, and D. D. Dougherty. 2019. Deep brain stimulation of the internal capsule enhances human cognitive control and prefrontal cortex function. Nature Communications 10(1):1536.
Zack, M. M., and R. Kobau. 2017. National and state estimates of the numbers of adults and children with active epilepsy—United States, 2015. Morbidity and Mortality Weekly Report 66:821–825.
This page intentionally left blank.